Our cross-national comparison of #analgesic use in Australian & Japanese RACFs🌎. Reasons for the huge (i.e. 30-fold) discrepancy in #opioid use may include:
❔Differences in pain assessment
❔Regulations/Restrictions
❔Treatment durations
Read here: https://t.co/QkdJGMdaVI
Excited to share our mixed-methods study on the pharmacological management of #pain in Australian & Japanese #nursinghomes. Huge differences in #analgesic use + some different approaches to pain management between countries @Lauradowd21@CentMedUseSafet https://t.co/pDF2sIt0hj
@CentMedUseSafet researchers have found 74% of Australia’s aged care population are prescribed regular painkiller medications and are 30 times more likely to use opioids, compared to Japan. Published in @Age_and_Ageing.
#MonashPharm#ChangeIt#Research
https://t.co/L7MsHLkwT9
👋We look forward to seeing you at the Australian Deprescribing Network (ADeN) 2023 Meeting on November 3rd!
👉Please remember to register for this event: https://t.co/HqfSdtR3BP
👉Check out the conference program here: https://t.co/qjOAdHWEAr
📜Have you written your abstract for the 2023 @DeprescribeAU annual meeting yet?
⏰Submissions close 30th of September!
ℹ️ Follow this link for more information https://t.co/MK5Ker65Ly
👀We can't wait to see you there!
I’ve had an amazing week in #Japan attending the #IAGG23 conference, connecting with our amazing Japanese collaborators and attending the baseball with @CentMedUseSafet colleagues! Feeling very grateful and inspired after this experience 🇯🇵#agedcare@MIPS_Australia@AmandaJCross
Amazing day of cross-national learning with @CentMedUseSafet and Japanese colleagues at Uni of Tokyo. We discussed our #agedcare systems & opportunities to share initiatives and setup new projects. We also visited a Japanese medical clinic & nursing home! @MIPS_Australia
A multidisciplinary analgesic stewardship approach may optimise pain management plans and reduce opioid usage in RACF residents. #agedcare#opioidstewardship https://t.co/O6CNmXNZQS
Nice work @Lauradowd21 ... Identifying residents who may benefit from analgesic review: applying analgesic indicators in residential #AgedCare services. Drugs Aging (2023). #medicinesafety#analgesicstewardship https://t.co/4jGIFncQwA
When applying 5 guideline-recommended indicators to a sample of Australian residents, 1 in 3 residents would benefit from analgesic review (mostly due to acetaminophen dose). Can #indicators be used to target interventions at the resident-level in RACFs?
https://t.co/IszKWqPPMe